Literature DB >> 32283233

Reply to "COVID-19 can present with a rash and be mistaken for dengue": Petechial rash in a patient with COVID-19 infection.

Juan Jimenez-Cauhe1, Daniel Ortega-Quijano2, Marta Prieto-Barrios2, Oscar M Moreno-Arrones2, Diego Fernandez-Nieto2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32283233      PMCID: PMC7151451          DOI: 10.1016/j.jaad.2020.04.016

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
To the Editor: We read with interest the article by Joob et al hypothesizing that COVID-19 infection might present with a skin rash and petechiae. During the COVID-19 outbreak in China, clinical studies did obviously not focus on the skin manifestations of COVID-19. However, it is likely they exist and are probably under-recognized because of the current lack of dermatology consultations in these patients. Recently, Recalcati et al reported the cutaneous manifestations of COVID-19 infection in Italy and described 3 main patterns: erythematous rash, urticaria, and chickenpox-like lesions. However, these 2 published articles did not include clinical images due to safety concerns with transmission of the virus or to a low suspicion of association with it. These weeks we are living the same dramatic situation in Spain, especially in Madrid, and we are beginning to observe some skin manifestations in patients with COVID-19 infection (Fig 1 ).
Fig 1

Purpuric skin rash in a patient with COVID-19 bilateral pneumonia, revealing purpuric, coalescing macules on (A) left and (B) right periaxillary regions.

Purpuric skin rash in a patient with COVID-19 bilateral pneumonia, revealing purpuric, coalescing macules on (A) left and (B) right periaxillary regions. Whether skin lesions in patients with COVID-19 infection are specific to COVID is still unclear. Viral rashes and drug reactions are clinically and histologically similar and often hard to distinguish. The patient pictured above received hydroxychloroquine and lopinavir/ritonavir, but drug reactions are rare with these agents. In addition, it is not unlikely that COVID-19 may have cutaneous manifestations, because it occurs with other common viral infections. A thorough history of the patient must be obtained to assess the etiology, especially possible eliciting drugs, and time relationship to both drug intake and onset of the COVID-19 symptoms. Dermatologists have a unique opportunity to study COVID-19 cutaneous manifestations during this pandemic, and illustrative images are the first step for other colleagues to start looking for them. A golden principle of medicine becomes now more important: “The more you see, the more you know; and the more you know is the more you see.”
  2 in total

1.  Cutaneous manifestations in COVID-19: a first perspective.

Authors:  S Recalcati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

2.  COVID-19 can present with a rash and be mistaken for dengue.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  J Am Acad Dermatol       Date:  2020-03-22       Impact factor: 15.487

  2 in total
  51 in total

Review 1.  Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).

Authors:  J M Carrascosa; V Morillas; I Bielsa; M Munera-Campos
Journal:  Actas Dermosifiliogr       Date:  2020-10-15

2.  A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations.

Authors:  Niloufar Najar Nobari; Farnoosh Seirafianpour; Milad Dodangeh; Afsaneh Sadeghzadeh-Bazargan; Elham Behrangi; Samaneh Mozafarpoor; Azadeh Goodarzi
Journal:  Exp Dermatol       Date:  2021-05-24       Impact factor: 4.511

Review 3.  Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review.

Authors:  Keyun Tang; Yuanzhuo Wang; Hanlin Zhang; Qingyue Zheng; Rouyu Fang; Qiuning Sun
Journal:  Dermatol Ther       Date:  2020-05-22       Impact factor: 2.851

Review 4.  Skin manifestations of COVID-19 in children: Part 2.

Authors:  D Andina; A Belloni-Fortina; C Bodemer; E Bonifazi; A Chiriac; I Colmenero; A Diociaiuti; M El-Hachem; L Fertitta; D van Gysel; A Hernández-Martín; T Hubiche; C Luca; L Martos-Cabrera; A Maruani; F Mazzotta; A D Akkaya; M Casals; J Ferrando; R Grimalt; I Grozdev; V Kinsler; M A Morren; M Munisami; A Nanda; M P Novoa; H Ott; S Pasmans; C Salavastru; V Zawar; A Torrelo
Journal:  Clin Exp Dermatol       Date:  2020-11-09       Impact factor: 4.481

5.  Cutaneous manifestations in COVID-19: familial cluster of urticarial rash.

Authors:  R Cepeda-Valdes; D Carrion-Alvarez; A Trejo-Castro; M Hernandez-Torre; J Salas-Alanis
Journal:  Clin Exp Dermatol       Date:  2020-06-22       Impact factor: 4.481

Review 6.  Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.

Authors:  P Gisondi; S PIaserico; C Bordin; M Alaibac; G Girolomoni; L Naldi
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-20       Impact factor: 9.228

7.  Rash as a presenting complaint in a child with COVID-19.

Authors:  Anna Klimach; Jordan Evans; Jennifer Stevens; Nikola Creasey
Journal:  Pediatr Dermatol       Date:  2020-07-16       Impact factor: 1.997

Review 8.  Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.

Authors:  A V Marzano; N Cassano; G Genovese; C Moltrasio; G A Vena
Journal:  Br J Dermatol       Date:  2020-07-05       Impact factor: 11.113

Review 9.  COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge.

Authors:  Jacek Baj; Hanna Karakuła-Juchnowicz; Grzegorz Teresiński; Grzegorz Buszewicz; Marzanna Ciesielka; Ryszard Sitarz; Alicja Forma; Kaja Karakuła; Wojciech Flieger; Piero Portincasa; Ryszard Maciejewski
Journal:  J Clin Med       Date:  2020-06-05       Impact factor: 4.241

10.  Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection.

Authors:  M C Annunziata; A Patrì; A Ruggiero; A Di Guida; C Menicanti; V Greco; G Fabbrocini
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-20       Impact factor: 9.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.